July 2019
Volume 60, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2019
Identifying Patients at Risk for Experiencing Rapid Progression of Open Angle Glaucoma Using Supervised Machine Learning
Author Affiliations & Notes
  • Isaac Jones
    Industrial and Operations Engineering, University of Michigan, Ann Arbor, Michigan, United States
  • Mark P Van Oyen
    Industrial and Operations Engineering, Univeristy of Michigan, Inkster, Michigan, United States
  • Mariel Lavieri
    Industrial and Operations Engineering, Univeristy of Michigan, Inkster, Michigan, United States
  • Chris Andrews
    Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, United States
    Center for Eye Policy and Innovation, University of Michigan, Ann Arbor, Michigan, United States
  • Joshua D Stein
    Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, United States
    Center for Eye Policy and Innovation, University of Michigan, Ann Arbor, Michigan, United States
  • Footnotes
    Commercial Relationships   Isaac Jones, None; Mark Van Oyen, None; Mariel Lavieri, None; Chris Andrews, None; Joshua Stein, None
  • Footnotes
    Support  Funding to support this research comes from the National Institutes of Health (Bethesda, MD) R01EY026641 (MSL/JDS) and an unrestricted grant from Research to Prevent Blindness (New York, NY) to the University of Michigan
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 2472. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Isaac Jones, Mark P Van Oyen, Mariel Lavieri, Chris Andrews, Joshua D Stein; Identifying Patients at Risk for Experiencing Rapid Progression of Open Angle Glaucoma Using Supervised Machine Learning. Invest. Ophthalmol. Vis. Sci. 2019;60(9):2472.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Although open-angle glaucoma (OAG) is often a slow insidiously progressive disease, occasionally patients experience rapid progression (RP), which can lead to irreversible blindness if not detected and treated promptly. We created novel supervised machine learning models using principal component analysis followed by a Soft Voting Ensemble classifier to identify the visits at which patients with OAG are about to experience RP over the next 3 years and may be at risk for blindness.

Methods : We studied 571 patients with OAG from the AGIS and CIGTS trials data sets. Patients underwent tonometry and perimetry every 6 months for 6 years duration. Our supervised machine learning algorithm processed the patient’s glaucoma trajectory during at least 2 years and then predicted at each visit if they would experience RP over the next 3 years of follow-up. We defined RP as a statistically significant (one sided α=0.05) rate of decrease in mean deviation (MD) of ≥1 dB/year, obtaining the slope from linear regression. We built a simple model using patient demographic characteristics and then a more complex model that, in addition, incorporated past IOP, MD, and PSD data. Model training and hyper-parameter selection were done using 5-fold cross validation, then performance was evaluated on a held out (20%) test set.

Results : As shown in Fig. 1, demographics alone have some predictive value, with 0.58 AUC at identifying visits where patients exhibit RP over 3 years of follow-up. Our full model that also incorporated tonometric and perimetric data achieved an AUC of 0.83 for predicting visits with RP.

Conclusions : Supervised learning algorithms that consider both a patient’s demographics and longitudinal results from tonometry and perimetry are capable of identifying with reasonable accuracy the times when patients experience RP of OAG. Incorporating additional parameters such as data from OCT are likely to enhance such predictions. With further enhancement of these models, they may soon be sufficiently accurate for clinicians to incorporate their results into clinical decision-making.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

 

<p align="center" style="margin: 0px; text-align: center;"><span style="font-family:courier new; margin:0px"><font color="#000000" size="3">Fig. 1. AUC classification results of 2 models </font></span></p>

<p align="center" style="margin: 0px; text-align: center;"><span style="font-family:courier new; margin:0px"><font color="#000000" size="3">Fig. 1. AUC classification results of 2 models </font></span></p>

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×